QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 25, no. 4 (2006): 1061-1069
doi: 10.1377/hlthaff.25.4.1061
© 2006 by Project HOPE
 
New Online
 * Pay Cuts For Medicare Docs
 * Access To Care Woes
 * Public Coverage More Efficient
 * Empowering Consumers
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when eLetters are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in ISI Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via ISI Web of Science (1)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Milstien, J. B.
* Articles by Kieny, M. P.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Milstien, J. B.
* Articles by Kieny, M. P.
Related Collections
* Access To Care
* Business Of Health
* Consumer Issues
* Health Promotion/Disease Prevention
* International Issues
* Vaccines
* Public Health

Health Tracking

MARKETWATCH

The Impact Of Globalization On Vaccine Development And Availability

Julie B. Milstien, Miloud Kaddar and Marie Paule Kieny

Globalization is likely to affect many aspects of public health, one of which is vaccine-preventable communicable diseases. Important forces include increased funding initiatives supporting immunization at the global level; regulatory harmonization; widespread intellectual property rights provisions through the World Trade Organization agreements; the emergence of developing-country manufacturers as major players in vaccine supply; and the appearance of new communicable disease threats, including those potentially linked to bioterrorism. All of these forces can affect, either positively and negatively, the development and availability of vaccines. Harnessing these will be a challenge for policymakers and immunization stakeholders.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
BMJHome page
D. A Chokshi and A. S Kesselheim
Rethinking global access to vaccines
BMJ, April 5, 2008; 336(7647): 750 - 753.
[Full Text] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2006 Project HOPE–The People-to-People Organization
Terms and Policies